Bicycle Therapeutics EPS Diluted from Accounting Change (Quarterly) Insights

Bicycle Therapeutics Plc (BCYC)

6.90 +0.23 (+3.45%) USD | NASDAQ | Jan 21, 16:00

6.90 0.00 (0.00%) After-Hours: 19:29

View EPS Diluted from Accounting Change (Quarterly) for BCYC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Accounting Change (Quarterly) Benchmarks

Start Trial

Biodexa Pharmaceuticals Plc	--
NuCana Plc	--
Mereo BioPharma Group Plc	--
Autolus Therapeutics Plc	--
DBV Technologies SA	--